
The Mesothelioma Center News – Page 16
-
Veterans & MilitaryOn Wednesday, Aug. 10, President Joe Biden signed the comprehensive Honoring Our PACT Act of 2022 into law, allowing military veterans and families harmed…
-
Research & Clinical Trials
Study Suggests Relationship Between Stromal Tumors and Mesothelioma
Early identification of peritoneal mesothelioma cancer – when it is most effectively treated – may become more common after a recent study revealed a… -
Asbestos Exposure & Bans
WHO Reclassifies Firefighting as High-Risk Occupation for Cancer
The World Health Organization has reclassified firefighting to its highest level of occupational risk for cancer after extensive research confirmed an alarming level of… -
Treatment & Doctors
UK Approves Opdivo/Yervoy Immunotherapy for Pleural Mesothelioma
Patients with unresectable pleural mesothelioma cancer throughout the United Kingdom will now have the immunotherapy combination of Opdivo and Yervoy as an option… -
Asbestos Exposure & Bans
Study: Those Exposed to Asbestos Should Not Take Beta-Carotene
Taking beta-carotene health supplements could increase the risk of lung cancer or death from cardiovascular disease for anyone who is regularly exposed to asbestos,… -
Treatment & Doctors
MARF to Host International Symposium on Malignant Mesothelioma
Leading medical specialists will gather with mesothelioma patients, families, friends and advocates at the much-anticipated 2022 International Symposium on Malignant Mesothelioma, July 23, in… -
Asbestos Exposure & Bans
New Study Underscores Importance of Worldwide Asbestos Ban
The push for a worldwide ban on asbestos gained momentum recently with the latest study linking national consumption levels of the toxic mineral with… -
Research & Clinical Trials
Researchers in Japan Study Inhalable Gene Therapy for Mesothelioma
Patients with malignant pleural mesothelioma may be turning to orally inhalable gene therapy in the future, easing the treatment burden for this cancer with… -
Asbestos Exposure & Bans
EPA Finalizes Asbestos Risk Evaluation Goals with Part 2 Assessment
Utilizing recent public feedback, the U.S. Environmental Protection Agency finalized its strategy and goals for the much-anticipated Risk Evaluation for Asbestos Part 2. Its… -
Research & Clinical Trials
Toronto Cancer Center Hosts SMARTEST Mesothelioma Clinical Trial
Princess Margaret Cancer Centre in Toronto recently opened a first-of-its-kind clinical trial that hopes to build on earlier pioneering efforts to turn…